Molecular regulatory mechanism of LILRB4 in the immune response.

IF 1.5 4区 医学 Q4 IMMUNOLOGY Central European Journal of Immunology Pub Date : 2023-01-01 DOI:10.5114/ceji.2023.125238
Haiyin Liu, Jun Yang, Jing Zhang, Peiyue Zhang, Mengting Zhang, Chaojun Yang, Li Liu, Cuiyuan Huang, Wei Wang, Yuhong Zhai, Jian Yang
{"title":"Molecular regulatory mechanism of LILRB4 in the immune response.","authors":"Haiyin Liu,&nbsp;Jun Yang,&nbsp;Jing Zhang,&nbsp;Peiyue Zhang,&nbsp;Mengting Zhang,&nbsp;Chaojun Yang,&nbsp;Li Liu,&nbsp;Cuiyuan Huang,&nbsp;Wei Wang,&nbsp;Yuhong Zhai,&nbsp;Jian Yang","doi":"10.5114/ceji.2023.125238","DOIUrl":null,"url":null,"abstract":"<p><p>Immune diseases are caused by the imbalance of immune regulation. This imbalance is regulated by many factors, both negative and positive. Leukocyte immunoglobulin-like receptor B4 (LILRB4) is a member of leukocyte immunoglobulin-like receptors (LILRs). LILRs are expressed constitutively on the surface of multiple immune cells which associate with membrane adaptors to signal through multi- ple cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs) or immunoreceptor tyro-sine-based activation motifs (ITAMs). Through ITIM, LILRB4 could recruit the src homology domain type-2-containing tyrosine phosphatase 1 or 2 (SHP-1 or SHP-2) into the cell membrane. In addition, many factors can induce the expression of LILRB4, such as vitamin D, interferon and so on. Studies have demonstrated that LILRB4 had a negative regulatory role in various of immune diseases. The present review intends to expound the structure and function of LILRB4, as well as its regulators and receptors in the immune cells, so as to provide a theoretical basis for immune disease therapy.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"48 1","pages":"43-47"},"PeriodicalIF":1.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/5e/CEJI-48-50171.PMC10189573.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5114/ceji.2023.125238","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Immune diseases are caused by the imbalance of immune regulation. This imbalance is regulated by many factors, both negative and positive. Leukocyte immunoglobulin-like receptor B4 (LILRB4) is a member of leukocyte immunoglobulin-like receptors (LILRs). LILRs are expressed constitutively on the surface of multiple immune cells which associate with membrane adaptors to signal through multi- ple cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs) or immunoreceptor tyro-sine-based activation motifs (ITAMs). Through ITIM, LILRB4 could recruit the src homology domain type-2-containing tyrosine phosphatase 1 or 2 (SHP-1 or SHP-2) into the cell membrane. In addition, many factors can induce the expression of LILRB4, such as vitamin D, interferon and so on. Studies have demonstrated that LILRB4 had a negative regulatory role in various of immune diseases. The present review intends to expound the structure and function of LILRB4, as well as its regulators and receptors in the immune cells, so as to provide a theoretical basis for immune disease therapy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
LILRB4在免疫应答中的分子调控机制。
免疫性疾病是由免疫调节失衡引起的。这种不平衡受到许多因素的调节,既有消极的因素,也有积极的因素。白细胞免疫球蛋白样受体B4 (LILRB4)是白细胞免疫球蛋白样受体(LILRs)的一个成员。lilr在多种免疫细胞表面组成性地表达,这些细胞通过多种细胞质免疫受体酪氨酸抑制基序(ITIMs)或免疫受体酪氨酸激活基序(ITAMs)与膜受体结合,发出信号。LILRB4通过ITIM将src同源结构域2型酪氨酸磷酸酶1或2 (SHP-1或SHP-2)募集到细胞膜内。此外,许多因素可以诱导LILRB4的表达,如维生素D、干扰素等。研究表明,LILRB4在多种免疫疾病中具有负调控作用。本文拟阐述LILRB4的结构和功能,以及其在免疫细胞中的调节因子和受体,为免疫疾病的治疗提供理论依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
17
审稿时长
6-12 weeks
期刊介绍: Central European Journal of Immunology is a English-language quarterly aimed mainly at immunologists.
期刊最新文献
Notch signaling pathway-based classification of bladder cancer in relation to tumor immune infiltration Interleukin-1 receptor-associated kinase 2 promotes inflammatory reactions by activating the nuclear factor kappa-B signaling pathway in diabetic nephropathy Influence of blood sample storage and different types of anticoagulants on results of NK cytotoxicity tests COVID-19 vaccination in healthcare workers: Long-term benefits and protection Efficacy of IL-23 inhibitors and IL-12/23 inhibitors in the induction treatment of Crohn’s disease: A meta-analysis based on randomized controlled trials
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1